Summary
Updated Aug 31, 2026
Patrick Lamy files SEC Form 4 reports at Akero Therapeutics, Inc. (AKRO). 5 SEC Form 4 filings on record going back to 2024, most recently on 9 December 2025. Most recent open-market trade: sold $106K of AKRO on 1 July 2025. Lifetime open-market sales: $163K.
Recent Transactions
7Every recent SEC Form 4 transaction Patrick Lamy has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Patrick Lamy files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Andrew Cheng - $2.99M of AKRO open-market activity in the last 12 months
- Jonathan Young - $1.20M of AKRO open-market activity in the last 12 months
- Timothy Rolph - $1.15M of AKRO open-market activity in the last 12 months
- William Richard White - $28K of AKRO open-market activity in the last 12 months
- Catriona Yale - $28K of AKRO open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Patrick Lamy?
Patrick Lamy is a corporate insider of Akero Therapeutics, Inc. (AKRO). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Patrick Lamy last file a Form 4?
The most recent primary Form 4 on record is dated 9 December 2025, one of 5 filings going back to 2024.
Has Patrick Lamy been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($163K) across all tracked filings.
Where can I see all of Patrick Lamy's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Patrick Lamy and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
